HomeCompareAGYTF vs PM

AGYTF vs PM: Dividend Comparison 2026

AGYTF yields 1818.18% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGYTF wins by $4103414683.79M in total portfolio value
10 years
AGYTF
AGYTF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full AGYTF calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — AGYTF vs PM

📍 AGYTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGYTFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGYTF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AGYTF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGYTF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, AGYTF beats the other by $3,147,377,270,440,828.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGYTF + PM for your $10,000?

AGYTF: 50%PM: 50%
100% PM50/50100% AGYTF
Portfolio after 10yr
$2051707341.94M
Annual income
$1,851,398,394,379,449.50/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

AGYTF
No analyst data
Altman Z
-5.5
Piotroski
2/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGYTF buys
0
PM buys
0
No recent congressional trades found for AGYTF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGYTFPM
Forward yield1818.18%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$4103414683.84M$49.6K
Annual income after 10y$3,702,796,788,756,407.00$2,492.02
Total dividends collected$4074760433.31M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: AGYTF vs PM ($10,000, DRIP)

YearAGYTF PortfolioAGYTF Income/yrPM PortfolioPM Income/yrGap
1← crossover$192,518$181,818.18$11,648$408.29+$180.9KAGYTF
2$3,477,331$3,271,336.99$13,589$495.90+$3.46MAGYTF
3$58,943,217$55,222,471.89$15,877$603.21+$58.93MAGYTF
4$937,891,469$874,822,227.57$18,580$734.88+$937.87MAGYTF
5$14,012,869,532$13,009,325,660.38$21,781$896.75+$14012.85MAGYTF
6$196,647,994,247$181,654,223,846.76$25,578$1,096.12+$196647.97MAGYTF
7$2,592,865,386,485$2,382,452,032,641.56$30,092$1,342.17+$2592865.36MAGYTF
8$32,132,661,421,271$29,358,295,457,731.54$35,470$1,646.46+$32132661.39MAGYTF
9$374,409,247,740,494$340,027,300,019,734.44$41,892$2,023.58+$374409247.70MAGYTF
10$4,103,414,683,838,736$3,702,796,788,756,407.00$49,578$2,492.02+$4103414683.79MAGYTF

AGYTF vs PM: Complete Analysis 2026

AGYTFStock

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Full AGYTF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this AGYTF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGYTF vs SCHDAGYTF vs JEPIAGYTF vs OAGYTF vs KOAGYTF vs MAINAGYTF vs MOAGYTF vs BTIAGYTF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.